{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:11Z","timestamp":1781530331664,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Leber hereditary optic neuropathy (LHON) is the most commonly diagnosed mitochondrial disorder, resulting in colour vision abnormalities and rapid but painless deterioration of central vision. While numerous studies have assessed the impact of LHON on the quality of life (QoL) of LHON patients, the financial impact of the disease remains unexplored. This study attempts to calculate both the direct non-medical costs and the indirect costs associated with productivity losses experienced by people with LHON and their unpaid caregivers in Slovenia, in addition to assessing their QoL. Due to the rarity of the disease, the study involved a small sample size, which is important to note for interpreting the results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The analysis was conducted on nine adult participants diagnosed with LHON, representing one-third of the total number of known Slovenian patients with this condition. To thoroughly assess the economic and social impact of LHON, tailored questionnaires were designed to collect information on demographics, socioeconomic status, LHON severity, and associated non-medical and indirect costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age of the study participants was 48.8 years (SD 13.3; <jats:italic>n<\/jats:italic>\u2009=\u20099). The annual productivity loss attributable to LHON, taking both absenteeism and relative presenteeism into account, was calculated to be EUR 11,608 per person affected. The mean VFQ-25 score, a measure of vision-related quality of life, for adult LHON patients was 30.4 (SD 12.9).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings highlight the significant economic and social burden of LHON on patients and their families. Ensuring prompt, accurate diagnosis, access to treatment, financial support, and psychological counselling and services are critical to helping individuals cope with and mitigate the profound challenges of vision loss and living with LHON.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03329-0","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:02:18Z","timestamp":1725044538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective"],"prefix":"10.1186","volume":"19","author":[{"given":"Marko","family":"Hawlina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-7416","authenticated-orcid":false,"given":"Katar\u00edna","family":"Brecikov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"\u017digmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Rogalewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Tichop\u00e1d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vi\u0161\u0148ansk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"\u0160arkanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"3329_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2008","unstructured":"Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2008;46:145\u201358. https:\/\/doi.org\/10.1136\/jmg.2007.054270.","journal-title":"J Med Genet"},{"key":"3329_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/jmg.39.3.162","volume":"39","author":"PYW Man","year":"2002","unstructured":"Man PYW. Leber hereditary optic neuropathy. J Med Genet. 2002;39:162\u20139. https:\/\/doi.org\/10.1136\/jmg.39.3.162.","journal-title":"J Med Genet"},{"issue":"1988","key":"3329_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1979","unstructured":"Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas LJ, Nikoskelainen EK. Mitochondrial DNA mutation Associated with Lebers Hereditary Optic Neuropathy. Science. 1979;242(1988):1427\u201330. https:\/\/doi.org\/10.1126\/science.3201231.","journal-title":"Science"},{"key":"3329_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/jmg.31.4.280","volume":"31","author":"RJ Oostra","year":"1994","unstructured":"Oostra RJ, Bolhuis PA, Wijburg FA, Zorn-Ende G, Bleeker-Wagemakers EM. Lebers hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome. J Med Genet. 1994;31:280\u20136. https:\/\/doi.org\/10.1136\/jmg.31.4.280.","journal-title":"J Med Genet"},{"key":"3329_CR5","doi-asserted-by":"publisher","unstructured":"Hage R, Vignal-Clermont C. Leber Hereditary Optic Neuropathy: review of treatment and management. Front Neurol. 2021;12. https:\/\/doi.org\/10.3389\/fneur.2021.651639.","DOI":"10.3389\/fneur.2021.651639"},{"key":"3329_CR6","doi-asserted-by":"publisher","unstructured":"Petrovic Pajic S, Jarc-Vidmar M, Fakin A, Sustar Habjan M, Brecelj J, Volk M, Maver A, Peterlin B, Hawlina M. Case report: long-term follow-up of two patients with LHON caused by DNAJC30:c.152G\u2009>\u2009A pathogenic variant-case series. Front Neurol. 2022;13. https:\/\/doi.org\/10.3389\/fneur.2022.1003046.","DOI":"10.3389\/fneur.2022.1003046"},{"key":"3329_CR7","doi-asserted-by":"publisher","unstructured":"Stenton SL, Sheremet NL, Catarino CB, Andreeva NA, Assouline Z, Barboni P, Barel O, Berutti R, Bychkov I, Caporali L, Capristo M, Carbonelli M, Cascavilla ML, Charbel Issa P, Freisinger P, Gerber S, Ghezzi D, Graf E, Heidler J, Hempel M, Heon E, Itkis YS, Javasky E, Kaplan J, Kopajtich R, Kornblum C, Kovacs-Nagy R, Krylova TD, Kunz WS, La Morgia C, Lamperti C, Ludwig C, Malacarne PF, Maresca A, Mayr JA, Meisterknecht J, Nevinitsyna TA, Palombo F, Pode-Shakked B, Shmelkova MS, Strom TM, Tagliavini F, Tzadok M, Van der Ven AT, Vignal-Clermont C, Wagner M, Zakharova EY, Zhorzholadze NV, Rozet JM, Carelli V, Tsygankova PG, Klopstock T, Wittig I, Prokisch H. Impaired complex I repair causes recessive Leber\u2019s hereditary optic neuropathy. J Clin Invest. 2021;131. https:\/\/doi.org\/10.1172\/JCI138267.","DOI":"10.1172\/JCI138267"},{"key":"3329_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.ejhg.5201828","volume":"15","author":"A Puomila","year":"2007","unstructured":"Puomila A, H\u00e4m\u00e4l\u00e4inen P, Kivioja S, Savontaus M-L, Koivum\u00e4ki S, Huoponen K, Nikoskelainen E. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet. 2007;15:1079\u201389. https:\/\/doi.org\/10.1038\/sj.ejhg.5201828.","journal-title":"Eur J Hum Genet"},{"key":"3329_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5301\/ejo.5000055","volume":"22","author":"B Mascialino","year":"2011","unstructured":"Mascialino B, Leinonen M, Meier T. Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe. Eur J Ophthalmol. 2011;22:461\u20135. https:\/\/doi.org\/10.5301\/ejo.5000055.","journal-title":"Eur J Ophthalmol"},{"key":"3329_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"PYW Man","year":"2003","unstructured":"Man PYW, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber Hereditary Optic Neuropathy in the North East of England. Am J Hum Genet. 2003;72:333\u20139. https:\/\/doi.org\/10.1086\/346066.","journal-title":"Am J Hum Genet"},{"key":"3329_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.24362","volume":"77","author":"GS Gorman","year":"2015","unstructured":"Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai\u2010Man P, Chinnery PF, Taylor RW, Turnbull DM, McFarland R. Prevalence of nuclear and mitochondrial\u2009<\u2009scp\u2009>\u2009DNA mutations related to adult mitochondrial disease. Ann Neurol. 2015;77:753\u20139. https:\/\/doi.org\/10.1002\/ana.24362.","journal-title":"Ann Neurol"},{"key":"3329_CR12","doi-asserted-by":"publisher","unstructured":"\u0160ega R, Burgar J, Fakin A, Petrovi\u0107 Paji\u0107 S, Volk M, Hawlina M, Glava\u010d D. Jarc-Vidmar, Leberjeva hereditarna opti\u010dna nevropatija \u2013 pregled bolezni z analizo prisotnosti v Sloveniji. Slovenian Med J. 2022;1\u201314. https:\/\/doi.org\/10.6016\/ZdravVestn.3234.","DOI":"10.6016\/ZdravVestn.3234"},{"key":"3329_CR13","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, Atawan A, Chattopadhyay S, Schubert M, Garip A, Kernt M, Petraki D, Rummey C, Leinonen M, Metz G, Griffiths PG, Meier T, Chinnery PF. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134:2677\u201386. https:\/\/doi.org\/10.1093\/brain\/awr170.","journal-title":"Brain"},{"key":"3329_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","volume":"37","author":"V Carelli","year":"2017","unstructured":"Carelli V, Carbonelli M, De Coo IF, Kawasaki A, Klopstock T, Lagr\u00e8ze WA, La Morgia C, Newman NJ, Orssaud C, Pott JWR, Sadun AA, Van Everdingen J, Vignal-Clermont C, Votruba M, Yu-Wai-Man P, Barboni P. International consensus statement on the clinical and therapeutic management of leber hereditary optic neuropathy. J Neuroophthalmol. 2017;37:371\u201381. https:\/\/doi.org\/10.1097\/WNO.0000000000000570.","journal-title":"J Neuroophthalmol"},{"key":"3329_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/WNO.0000000000001023","volume":"40","author":"CB Catarino","year":"2020","unstructured":"Catarino CB, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, Castillo L, Friedburg C, Halfpenny CA, Lincoln JA, Traber GL, Acaroglu G, Black GCM, Doncel C, Fraser CL, Jakubaszko J, Landau K, Langenegger SJ, Mu\u00f1oz-Negrete FJ, Newman NJ, Poulton J, Scoppettuolo E, Subramanian P, Toosy AT, Vidal M, Vincent AL, Votruba M, Zarowski M, Zermansky A, Lob F, Rudolph G, Mikazans O, Silva M, Ll\u00f2ria X, Metz G. Klopstock, Real-World Clinical Experience with Idebenone in the treatment of Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2020;40:558\u201365. https:\/\/doi.org\/10.1097\/WNO.0000000000001023.","journal-title":"J Neuroophthalmol"},{"key":"3329_CR16","doi-asserted-by":"publisher","unstructured":"Pemp B, Kircher K, Reitner A. Visual function in chronic Leber\u2019s hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2019;257. https:\/\/doi.org\/10.1007\/s00417-019-04444-6.","DOI":"10.1007\/s00417-019-04444-6"},{"key":"3329_CR17","doi-asserted-by":"publisher","unstructured":"Balt\u0103 G, Cristache G, Barac AD, Anton N, Barac IR. Leber\u2019s Hereditary Optic Neuropathy (LHON): clinical experience and outcomes after long-term Idebenone Treatment. Life. 2023;13. https:\/\/doi.org\/10.3390\/life13102000.","DOI":"10.3390\/life13102000"},{"key":"3329_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0264619615616260","volume":"34","author":"J Ferguson","year":"2016","unstructured":"Ferguson J, de Abreu G. What is the lived experience for people with Leber Hereditary Optic Neuropathy? Br J Visual Impairment. 2016;34:109\u201320. https:\/\/doi.org\/10.1177\/0264619615616260.","journal-title":"Br J Visual Impairment"},{"key":"3329_CR19","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1167\/iovs.08-3166","volume":"50","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, de Coo IF, Klopstock T, Griffiths PG, Hudson G, Chinnery PF. Yu-Wai-Man, Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112\u20135. https:\/\/doi.org\/10.1167\/iovs.08-3166.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3329_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/WNO.0000000000000644","volume":"39","author":"S Cui","year":"2019","unstructured":"Cui S, Jiang H, Peng J, Wang J, Zhang X. Evaluation of vision-related quality of life in Chinese patients with Leber Hereditary Optic Neuropathy and the G11778A mutation. J Neuroophthalmol. 2019;39:56\u20139. https:\/\/doi.org\/10.1097\/WNO.0000000000000644.","journal-title":"J Neuroophthalmol"},{"key":"3329_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/01.jom.0000052967.43131.51","volume":"45","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Barber C, Beck A, Berglund P, Cleary PD, McKenas D, Pronk N, Simon G, Stang P, Ustun TB, Wang P. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med. 2003;45:156\u201374. https:\/\/doi.org\/10.1097\/01.jom.0000052967.43131.51.","journal-title":"J Occup Environ Med"},{"key":"3329_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM. Development of the 25-list-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050. https:\/\/doi.org\/10.1001\/archopht.119.7.1050.","journal-title":"Arch Ophthalmol"},{"key":"3329_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","volume":"17","author":"G Yang","year":"2022","unstructured":"Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022;17:163. https:\/\/doi.org\/10.1186\/s13023-022-02299-5.","journal-title":"Orphanet J Rare Dis"},{"key":"3329_CR24","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.2147\/OPTH.S313719","volume":"15","author":"J Gong","year":"2021","unstructured":"Gong J, Cheung S, Fasso-Opie A, Galvin O, Moniz LS, Earle D, Durham T, Menzo J, Li N, Duffy S, Dolgin J, Shearman MS, Fiorani C, Banhazi J, Daly A. The impact of inherited retinal diseases in the United States of America (US) and Canada from a cost-of-illness perspective. Clin Ophthalmol. 2021;15:2855\u201366. https:\/\/doi.org\/10.2147\/OPTH.S313719.","journal-title":"Clin Ophthalmol"},{"key":"3329_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/opth.s241928","volume":"14","author":"O Galvin","year":"2020","unstructured":"Galvin O, Chi G, Brady L, Hippert C, Rubido MDV, Daly A, Michaelides M. The impact of inherited retinal diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a cost-of-illness perspective. Clin Ophthalmol Volume. 2020;14:707\u201319. https:\/\/doi.org\/10.2147\/opth.s241928.","journal-title":"Clin Ophthalmol Volume"},{"key":"3329_CR26","doi-asserted-by":"publisher","unstructured":"Garcia GA, Khoshnevis M, Gale J, Frousiakis SE, Hwang TJ, Poincenot L, Karanjia R, Baron D, Sadun AA. Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clin Ophthalmol. 2017;11. https:\/\/doi.org\/10.2147\/OPTH.S113414.","DOI":"10.2147\/OPTH.S113414"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03329-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:02:27Z","timestamp":1725044547000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03329-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3329"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03329-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by Medical Ethics Committee of the Ministry of Health of the Republic of Slovenia under the reference number 0120\u2013407\/2022\/13.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}